The beginning of state-of-the-art total healthcare for your health
Since its establishment in 2000, KOLON LIFE SCIENCES has been providing optimal solutions for a healthy life by nurturing pharmaceuticals, specialty chemicals, water solution businesses, and new biopharmaceutical businesses, a new growth engine....More
We produce and supply chemical materials such as API (Active Pharmaceutical Ingredients) and advanced intermediates through our pharmaceutical business, CleanBio antibacterial in our specialty chemical business, and Besfloc (water treatment agents) through our water solution business.
As a global top-tier company, we lead the product market and strive to develop new biopharmaceuticals based on our accumulated experiences and capabilities.
Our mission is to become a global leader in life science innovation from bio to chemicals.
|Year of Establishment
|110 Kolon One & Only Tower, Magok-dong-ro, Gangseo-gu, Seoul
|Active Pharmaceutical Ingredients (API), CleanBio (Antimicrobial Agent), BESFLOC (Water Treatment Products)
KOLON PHARMA started as the Samyoung Chemical Research Institute in 1958 and was incorporated into KOLON Group in 1983. As a total health care company, we produce and distribute healthcare products such as prescription drugs, over-the-counter drugs, and health functional foods....More
We introduce new drugs through partnerships with leading pharmaceutical companies and develop and supply various prescription drugs in respiratory medicine, dermatology, pediatrics, and orthopedics. We also supply various over-the-counter drugs and health functional food products, including Apniben Q, the first mouthwash-type stomatitis treatment, and Bicogreen S Tablet, a three-component constipation treatment.
Our main products in each field maintain top positions in market share and are recognized for their value.
KOLON PHARMA aims to become a total healthcare company by developing differentiated medicines and entering various healthcare markets.
|Year of Establishment
|6F, KOLON Tower(Annex), 13, Kolon-ro, Gwacheon-si, Gyeonggi-do, Korea
|BICOGREEN S Tablets, COMY Syrup and Tablets, Topisol Milk Lotion, Foster 100/6 HFA, Curosurf
KOLON TISSUEGENE develops advanced cell therapies for researching and developing ligament damage treatment and cartilage regeneration promoters....More
We use our TG-C platform, a cellular gene technology, to develop new drugs and succeeded in obtaining a US patent for Gene therapy using TGF-β1 in September 2004. Our mission is to provide safe and effective therapies to patients by developing osteoarthritis treatments for improving clinical symptoms (pain relief, functional improvement) through tissue engineering and suppressing the progress of various degenerative diseases.
In addition, we have been operating and managing the W-STORE online mall, which sells health and beauty products, since August 2017.
KOLON Group's mobile web is optimized for vertical screens.